Sales to customers decreased 17.6 % year-on-year to 6,906 million yen.
Overall sales stagnated due to the foreign currency exchange impact of
the strong yen as well as falling sales of the core lip cream products
and slower sales of "Oxy," which continued to face fierce competition.
Meanwhile, sales of eye drops were strong partly benefited from the launch
of an eye drop for dry eye.
Segment profit (operating income) returned to profit and reached 96 million
yen (compared with 266 million yen loss in the previous fiscal year) due
to effective use of advertising and sales promotion expenses.